tiprankstipranks
Cannara Biotech (TSE:LOVE)
TSXV:LOVE
Holding TSE:LOVE?
Track your performance easily

Cannara Biotech (LOVE) Financial Statements

27 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently ―. The company's EPS TTM is C$0.071; its P/E ratio is 10.63; Cannara Biotech is scheduled to report earnings on January 27, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total RevenueC$ 7.89MC$ 27.56MC$ 27.21MC$ 19.48MC$ 18.28M
Gross ProfitC$ -8.81MC$ 13.77MC$ 14.67MC$ 7.94MC$ 6.89M
EBITC$ 5.32MC$ 3.55MC$ -3.45MC$ 3.49MC$ 6.29M
EBITDAC$ 7.09MC$ 5.07MC$ -1.99MC$ 5.11MC$ 7.61M
Net Income Common StockholdersC$ 5.75MC$ 2.02MC$ -3.45MC$ 2.11MC$ 4.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 6.62MC$ 5.46MC$ 3.13MC$ 2.64MC$ 4.27M
Total AssetsC$ 154.72MC$ 148.77MC$ 145.82MC$ 144.82MC$ 141.52M
Total DebtC$ 42.07MC$ 42.62MC$ 42.95MC$ 42.15MC$ 41.78M
Net DebtC$ 35.45MC$ 37.16MC$ 39.82MC$ 39.52MC$ 37.51M
Total LiabilitiesC$ 66.77MC$ 67.00MC$ 66.48MC$ 62.96MC$ 61.78M
Stockholders EquityC$ 87.95MC$ 81.77MC$ 79.34MC$ 81.86MC$ 79.74M
Cash Flow-
Free Cash FlowC$ 180.17KC$ 6.35MC$ 1.22MC$ -2.41MC$ 1.18M
Operating Cash FlowC$ 3.67MC$ 4.33MC$ 2.33MC$ 354.22KC$ 2.84M
Investing Cash FlowC$ -436.19KC$ -944.20KC$ -1.08MC$ -2.73MC$ -1.63M
Financing Cash FlowC$ -2.08MC$ -1.05MC$ -768.49KC$ 747.32KC$ -973.30K
Currency in CAD

Cannara Biotech Earnings and Revenue History

Cannara Biotech Debt to Assets

Cannara Biotech Cash Flow

Cannara Biotech Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis